Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Silvestris, Nicola ^a   Pantano, Francesco ^b   Ibrahim, Toni ^c   Gamucci, Teresa ^d   De Vita, Fernando ^e   Di Palma, Teresa ^f   Pedrazzoli, Paolo ^g   Barni, Sandro ^h   Bernardo, Antonio ⁱ   Febbraro, Antonio ^j   Satolli, Maria Antonietta ^k   Bertocchi, Paola ^l   Catalano, Vincenzo ^m   Giommoni, Elisa ⁿ   Comandone, Alessandro ^o   Maiello, Evaristo ^p   Riccardi, Ferdinando ^q   Ferrara, Raimondo ^r   Trogu, Antonio ^s   Berardi, Rossana ^t   Leo, Silvana ^u   Bertolini, Alessandro ^v   Angelini, Francesco ^w   Cinieri, Saverio ^x   Russo, Antonio ^y   Pisconti, Salvatore ^z   Brunetti, Anna Elisabetta ^a   Azzariti, Amalia ^a   Santini, Daniele ^b   more..

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^d Frosinone Hospital   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f Latina Hospital   (Italy)

^g Rehabilitation Institute of Pavia   (Italy)

^h Treviglio Caravaggio Hospital   (Italy)

ⁱ IRCCS   (Italy)

^j University of Benevento   (Italy)

^k MOLINETTE HOSPITAL   (Italy)

^l Gastroenterology Unit   (Italy)

^m SAN SALVATORE HOSPITAL   (Italy)

ⁿ CAREGGI UNIVERSITY HOSPITAL   (Italy)

^o GRADENIGO HOSPITAL   (Italy)

^p CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^q CARDARELLI HOSPITAL   (Italy)

^r Hospital of Barletta   (Italy)

^s Aosta Hospital   (Italy)

^t UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^u Department of Mental Health   (Italy)

^v Hospital of Sondrio   (Italy)

^w Section of Pediatrics   (Italy)

^x EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^y UNIVERSITY OF PALERMO   (Italy)

^z Hospital of Taranto   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID; ZOLEDRONIC ACID;

ADULT; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PATIENT OUTCOME ASSESSMENT; POPULATION SURVEILLANCE; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84886612791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074402     Document Type: Article

References (25)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Guggenheim DE, Shah MA, (2013) Gastric cancer epidemiology and risk factors. J Surg Oncol 107: 230-236.
3. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, et al. (2004) Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240: 808-816.
4. Park HS, Rha SY, Kim HS, Hyung WJ, Park JS, et al. (2011) A Prognostic Model to Predict Clinical Outcome in Gastric Cancer Patients with Bone Metastasis. Oncology 80: 142-150.
5. Lipton A, Cook R, Brown J, Body JJ, Smith M, et al. (2013) Skeletal-related Events and Clinical Outcomes in Patients with Bone Metastases and Normal Levels of Osteolysis: Exploratory Analyses. Clin Oncol (R Coll Radiol) 25: 217-226.
6. Kaplan E, Meier P, (1958) Non parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481.
7. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, et al. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 35: 1-39.
8. Crivellari D, Carbone A, Sigon R, Buonadonna A, Cannizzaro R, et al. (1995) Gastric cancer with bone marrow invasion at presentation: case-report and review of the literature. Tumori 81: 74-76.
9. Abrams HL, Spiro R, Goldstein N, (1950) Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 3: 74-85.
10. Yoshikawa K, Kitaoka H, (1983) Bone metastasis of gastric cancer. Jpn J Surg 13: 173-176.
11. Seto M, Tonami N, Koizumi K, Sui O, Hisada K, (1983) Bone metastasis in gastric cancer-clinical evaluation of bone scintigrams. Kaku Igaku 20: 795-801.
12. Park JM, Song KY, O JH, Kim WC, Choi MG, et al. (2012) Bone recurrence after curative resection of gastric cancer. Gastric Cancer 16: 362-369.
13. Nakanishi H, Araki N, Kuratsu S, Narahara H, Ishikawa O, et al. (2004) Skeletal metastasis in patients with gastric cancer. Clin Orthop Relat Res 42: 208-212.
14. Major PP, Cook RJ, Lipton A, Smith MR, Terpos E, et al. (2009) Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity. BMC Cancer 9: 272-284.
15. Park HS, Rha SY, Kim HS, Hyung WJ, Park JS, et al. (2011) A Prognostic Model to Predict Clinical Outcome in Gastric Cancer Patients with Bone Metastasis. Oncology 80: 142-150.
16. Xu D, Huang Y, Geng Q, Guan Y, Li Y, et al. (2012) Effect of Lymph Node Number on Survival of Patients with Lymph Node-Negative Gastric Cancer according to the 7th Edition UICC TNM System. PLoS One 7: e38681.
17. Saito H, Kuroda H, Matsunaga T, Fukuda K, Tatebe S, (2010) Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol 101: 622-625.
18. Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, (2010) A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 252: 70-73.
19. Major P, Lortholary A, Hon J, Abdi E, Mills G, et al. (2001) Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 19: 558-567.
20. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, et al. (1996) Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. N Engl J Med 335: 1785-1791.
21. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, et al. (1996) Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med 334: 488-493.
22. Rosen LS, Gordon D, Tchekmedyian S, Yanagihara R, Hirsh V, et al. (2003) Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial-the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 21: 3150-3157.
23. Henry DH, Costa L, Goldwasser F, Hirsh V, Hungria V, et al. (2011) Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 29: 1125-1132.
24. Santini D, Tampellini M, Vincenzi B, Ibrahim T, Ortega C, et al. (2012) Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol 23: 2072-2077.
25. Mortimer JE, Pal SK, (2010) Safety considerations for use of bone-targeted agents in patients with cancer. Semin Oncol 37(Suppl. 1): S66-72.